Cebix is a biopharmaceutical company developing treatments for diabetic complications that affect the function of nerves, kidneys and eyes.
Industries BiotechnologyHealth CarePharmaceuticalTherapeuticsHeadquarters Regions Greater San Diego Area, West Coast, Western US Founded Date 2008 Founders Lars Ekman Operating Status Active Last Funding Type Venture - Series Unknown Also Known As CEBIX INCOPRATED Legal Name Cebix, Inc
Company Type For Profit
Contact Email info@cebix.com Phone Number (858) 729-6500
Cebix is focused on the development of chronic replacement therapy based on human proinsulin C-peptide for the treatment of type 1 diabetic neuropathy. The role of C-peptide will also be explored in type 1 diabetic nephropathy and retinopathy.